BioMarin Pharmaceuticals BMRN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.07B+193% | $1.31B+39.1% | $1.25B+85.1% | $1.21B+24.9% | $1.05B+40.4% | ||
| $0-100% | $248.93M+27.7% | $227.73M-10.7% | $218.31M-13.4% | $223.53M-25.4% | ||
| $903.91M+22.3% | $908.21M+37.5% | $790.27M+1.6% | $855.86M+23.8% | $739.18M+16.0% | ||
| $1.27B-0.1% | $1.3B+5.4% | $1.38B+17.2% | $1.34B+13.2% | $1.27B+12.0% | ||
| $97.85M-39.8% | $106.51M-31.0% | $115.3M-20.2% | $119.75M-22.3% | $162.49M+9.7% | ||
| $1.05B+64.0% | $801.06M+45.5% | $781.17M+56.5% | $739.52M+22.1% | $642.99M+7.3% | ||
| $120.76M-74.3% | $391.31M-25.8% | $485.7M-9.3% | $480.89M+13.5% | $469.36M+20.2% | ||
| $205.5M+13.2% | $185.78M-7.8% | $204.27M+20.7% | $177.18M+10.4% | $181.55M+11.2% | ||
| $4.61B+32.8% | $3.95B+22.3% | $3.85B+26.1% | $3.81B+16.7% | $3.47B+16.2% | ||
| $958.07M-7.2% | $952.51M-8.7% | $1.04B-0.7% | $1.03B-2.1% | $1.03B-2.6% | ||
| $1.09B+20.5% | $1.07B+20.5% | $949.66M+9.3% | $931.02M+2.3% | $908.19M+2.3% | ||
| $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | ||
| $204.66M-17.3% | $213.84M-16.2% | $233.11M-10.7% | $239.62M-9.8% | $247.35M-11.6% | ||
| $1.5B+2.7% | $1.51B+1.3% | $1.51B-1.4% | $1.43B-7.6% | $1.46B-5.5% | ||
| $276.42M+17.3% | $277.05M+10.2% | $270.78M+35.9% | $249.19M+30.6% | $235.65M+27.5% | ||
| $0-100% | $492.24M-5.6% | $512.94M-8.7% | $508.59M-8.7% | $506.72M-18.3% | ||
| $8.59B+20.2% | $7.59B+8.7% | $7.61B+11.1% | $7.46B+5.5% | $7.15B+4.0% | ||
| $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M+19.5% | $628.21M+5.8% | ||
| $152.61M+17.2% | $219.42M+8.3% | $177.76M-11.2% | $119.41M-19.2% | $130.23M-12.3% | ||
| $3.01M-87.4% | $3.67M-70.8% | $22.61M+7.4% | $13.4M-29.0% | $23.94M+294% | ||
| —— | —— | —— | —— | —— | ||
| $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M-35.9% | $628.21M-42.3% | ||
| $1.43B— | $597.18M— | —— | —— | —— | ||
| $155.48M+19.9% | $150.82M+17.1% | $163.06M+27.9% | $148.82M+24.7% | $129.69M+10.5% | ||
| $2.38B+75.8% | $1.51B+13.2% | $1.56B+8.4% | $1.43B-19.7% | $1.35B-24.8% | ||
| 500M0.0% | 500M+261,680% | 500M0.0% | 500M0.0% | 500M0.0% | ||
| $5.97B+3.0% | $5.96B+2.7% | $5.9B+2.8% | $5.85B+2.7% | $5.79B+3.1% | ||
| $259.73M+2,983% | $154.21M+179% | $200.78M+163% | $231.52M+154% | -$9.01M+98.3% | ||
| -$4.24M-122% | -$13.47M-122% | -$33.94M-830% | -$44.57M-266% | $19.15M+1,931% | ||
| $6.21B+7.2% | $6.09B+7.6% | $6.06B+11.9% | $6.03B+14.0% | $5.79B+14.2% | ||
| $8.59B+20.2% | $7.59B+8.7% | $7.61B+11.1% | $7.46B+5.5% | $7.15B+4.0% | ||
| $3.07B+73.1% | $2.05B+23.6% | $1.99B+33.8% | $1.94B+8.6% | $1.78B+6.4% | ||
| $3.07B+72.7% | $2.05B+23.7% | $1.99B+33.4% | $1.94B+8.9% | $1.78B+6.7% | ||
| $0-100% | $248.93M+27.7% | $227.73M-10.7% | $218.31M-13.4% | $223.53M-25.4% | ||
| $120.76M-74.3% | $391.31M-25.8% | $485.7M-9.3% | $480.89M+13.5% | $469.36M+20.2% | ||
| $205.5M+13.2% | $185.78M-7.8% | $204.27M+20.7% | $177.18M+10.4% | $181.55M+11.2% | ||
| $35.06M-6.4% | $25.66M-67.8% | $24.59M+27.3% | $22.72M-40.5% | $37.47M+144% | ||
| $276.42M+17.3% | $277.05M+10.2% | $270.78M+35.9% | $249.19M+30.6% | $235.65M+27.5% | ||
| $722.36M+0.2% | $723.97M+0.4% | $722.74M+1.2% | $721.32M+1.5% | $721.11M+1.6% | ||
| $3.07B+73.1% | $2.05B+23.6% | $1.99B+33.8% | $1.94B+8.6% | $1.78B+6.4% | ||
| $0-100% | $492.24M-5.6% | $512.94M-8.7% | $508.59M-8.7% | $506.72M-18.3% | ||
| $1.5B+2.7% | $1.51B+1.3% | $1.51B-1.4% | $1.43B-7.6% | $1.46B-5.5% | ||
| $204.66M-17.3% | $213.84M-16.2% | $233.11M-10.7% | $239.62M-9.8% | $247.35M-11.6% | ||
| $204.66M-17.3% | $213.84M-16.2% | $233.11M-10.7% | $239.62M-9.8% | $247.35M-11.6% | ||
| $276.42M+17.3% | $277.05M+10.2% | $270.78M+35.9% | $249.19M+30.6% | $235.65M+27.5% | ||
| $2.05B+5.7% | $2.03B+4.8% | $1.99B+3.8% | $1.96B-0.1% | $1.94B-0.4% | ||
| $276.42M+17.3% | $277.05M+10.2% | $270.78M+35.9% | $249.19M+30.6% | $235.65M+27.5% | ||
| $395.47M+34.6% | $312.77M+32.9% | $389.67M+24.8% | $310.8M+20.7% | $293.75M+0.5% | ||
| $152.61M+17.2% | $219.42M+8.3% | $177.76M-11.2% | $119.41M-19.2% | $130.23M-12.3% | ||
| $6.66M-15.3% | $7.97M+0.6% | $6.95M-7.3% | $8.02M+4.5% | $7.86M-22.9% | ||
| $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M+19.5% | $628.21M+5.8% | ||
| $3.01M-87.4% | $3.67M-70.8% | $22.61M+7.4% | $13.4M-29.0% | $23.94M+294% | ||
| $31.68M+104% | $31.01M+137% | $43.74M+206% | $55.31M+620% | $15.52M+13.5% | ||
| $152.61M+17.2% | $219.42M+8.3% | $177.76M-11.2% | $119.41M-19.2% | $130.23M-12.3% | ||
| $31.68M+104% | $31.01M+137% | $43.74M+206% | $55.31M+620% | $15.52M+13.5% | ||
| —— | —— | —— | —— | —— | ||
| $7.29M-39.3% | $7.68M+7.9% | $10.1M+24.7% | $6.45M-9.2% | $12.02M+58.9% | ||
| $1.43B+138% | $642.87M+1,556% | $600M0.0% | $600M-62.4% | $600M-62.4% | ||
| —— | —— | —— | —— | —— | ||
| $10.45M-6.5% | $10.51M-6.4% | $11.29M-3.6% | $11.67M0.0% | $11.18M-4.5% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 193.3M+0.8% | 192.3M+0.8% | 192.1M+0.8% | 192M+0.9% | 191.8M+1.0% | ||
| $5.97B+3.0% | $5.96B+2.7% | $5.9B+2.8% | $5.85B+2.7% | $5.79B+3.1% | ||
| $193K+0.5% | $192K+0.5% | $192K+0.5% | $192K+1.1% | $192K+1.1% | ||
| $0-100% | $4.9M+56.5% | $4.93M-39.2% | $4.31M+430% | $4.05M+126% | ||
| $0-100% | $8K-99.0% | $55K-67.6% | $106K-96.0% | $245K-91.6% | ||
| $3.07B+73.1% | $2.05B+23.6% | $1.99B+33.8% | $1.94B+8.6% | $1.78B+6.4% | ||
| $38.58M+132% | $40.91M+162% | $58.54M+198% | $72M+705% | $16.66M+2.9% | ||
| $38.58M+132% | $40.91M+162% | $58.54M+198% | $72M+705% | $16.66M+2.9% | ||
| $177.66M+28.2% | $166.93M+38.1% | $140.05M-1.3% | $163.17M+43.8% | $138.59M+36.4% | ||
| $6.66M-15.3% | $7.97M+0.6% | $6.95M-7.3% | $8.02M+4.5% | $7.86M-22.9% | ||
| $0-100% | $8K-99.0% | $55K-67.6% | $106K-96.0% | $245K-91.6% | ||
| $0-100% | $4.9M+56.5% | $4.93M-39.2% | $4.31M+430% | $4.05M+126% | ||
| $3.07B+73.1% | $2.05B+23.6% | $1.99B+33.8% | $1.94B+8.6% | $1.78B+6.4% | ||
| $3.07B+72.7% | $2.05B+23.7% | $1.99B+33.4% | $1.94B+8.9% | $1.78B+6.7% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $500M0.0% | $500M0.0% | $500M0.0% | $500M0.0% | $500M0.0% | ||
| $193.27M+0.8% | $192.3M+0.8% | $192.1M+0.8% | $192M+0.9% | $191.76M+1.0% | ||
| $193.27M+0.8% | $192.3M+0.8% | $192.1M+0.8% | $192M+0.9% | $191.76M+1.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $35.06M-6.4% | $25.66M-67.8% | $24.59M+27.3% | $22.72M-40.5% | $37.47M+144% | ||
| $38.58M+132% | $40.91M+162% | $58.54M+198% | $72M+705% | $16.66M+2.9% | ||
| $517.7M+9.3% | $510.13M+9.5% | $489.63M+8.1% | $481.7M+8.2% | $473.76M+10.2% | ||
| $722.36M+0.2% | $723.97M+0.4% | $722.74M+1.2% | $721.32M+1.5% | $721.11M+1.6% | ||
| $9.32M+47.7% | $8.69M+14.7% | $7.58M-6.0% | $7.7M-27.9% | $6.31M-26.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) holds $8.6B in total assets, up 20.2% year over year.
- How much debt does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals carries $1.4B in total debt against $6.2B of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals holds $3.1B in cash and equivalents.
- Can BioMarin Pharmaceuticals cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does BioMarin Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
